Maharaj Masha, Korowlay Nisaar, Ellmann Prof
Department of Nuclear Medicine, Umhlanga Molecular Imaging and Therapy, Centre of Excellence, Umhlanga, South Africa.
Department of Medical Imaging and Clinical Oncology, Stellenbosch University, and Tygerberg Hospital, South Africa.
World J Nucl Med. 2016 Jan-Apr;15(1):50-2. doi: 10.4103/1450-1147.167600.
Adamantinoma is a rare locally aggressive osteolytic tumor that is found 90% of the time in the diaphysis of the tibia with the remaining lesions found in the fibula and long tubular bones. A case of adamantinoma of the tibia is presented. The added value of nuclear medicine investigations in the workup of this patient is described. A three-phase whole body (99m)Tc-methylene diphosphonate bone and a whole body (99m)Tc-methoxy-isobutyl-isonitrile scans were complimentary in the demarcation of viable bone tumor and the assessment of the remainder of the bone and soft tissue to exclude other sites. Intra-operative assistance with a hand-held gamma probe, guided the biopsy of the most metabolically active tumor tissue. Histology revealed a biphasic tumor composed of epithelial and fibrous components, in keeping with an adamantinoma.
造釉细胞瘤是一种罕见的具有局部侵袭性的溶骨性肿瘤,90%的病例发生于胫骨骨干,其余病变见于腓骨和长管状骨。本文报告1例胫骨造釉细胞瘤病例,并描述核医学检查在该患者检查中的附加价值。三相全身(99m)锝-亚甲基二膦酸盐骨扫描和全身(99m)锝-甲氧基异丁基异腈扫描在区分存活骨肿瘤以及评估其余骨骼和软组织以排除其他部位方面具有互补性。术中使用手持γ探头辅助,引导对代谢最活跃的肿瘤组织进行活检。组织学检查显示肿瘤呈双相性,由上皮和纤维成分组成,符合造釉细胞瘤表现。